Can Elevance Offset Rising Expenses in Q4 With Higher Premiums?

Key Takeaways Elevance Health's Q4 EPS is expected at $3.10, down 19.3% year over year, even as revenues rise 10.2%.ELV's premiums are projected to jump 12.3%, with product revenues up 1.5%, supporting Q4 sales growth.ELV faces margin pressure from higher benefit ratios and rising operating expenses.Elevance Health, Inc. (ELV) is set to report its fourth-quarter 2025 results on Jan. 28, 2026, before the opening bell. The Zacks Consensus Estimate for the to-be-reported quarter’s earnings is currently pegged ...